Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) Gross Margin (2016 - 2025)

InspireMD's Gross Margin history spans 16 years, with the latest figure at 37.47% for Q4 2025.

  • For Q4 2025, Gross Margin rose 1341.0% year-over-year to 37.47%; the TTM value through Dec 2025 reached 29.5%, up 802.0%, while the annual FY2025 figure was 29.5%, 802.0% up from the prior year.
  • Gross Margin reached 37.47% in Q4 2025 per NSPR's latest filing, up from 34.24% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 37.47% in Q4 2025 to a low of 8.59% in Q3 2021.
  • Average Gross Margin over 5 years is 22.97%, with a median of 23.47% recorded in 2024.
  • The largest YoY upside for Gross Margin was 26814bps in 2021 against a maximum downside of -2182bps in 2021.
  • A 5-year view of Gross Margin shows it stood at 21.3% in 2021, then fell by -9bps to 19.3% in 2022, then surged by 49bps to 28.68% in 2023, then decreased by -16bps to 24.06% in 2024, then skyrocketed by 56bps to 37.47% in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Gross Margin are 37.47% (Q4 2025), 34.24% (Q3 2025), and 17.6% (Q2 2025).